In mixed lineage leukemia-rearranged (MLL-r) leukemia, downregulation of LAMP5 led to inhibition of NFκB signaling and increased activation of type-1 interferon signaling downstream of Toll-like receptor/interleukin 1 receptor activation in-vivo and in-vitro (163). Here, KMT2A is linked to leukemia.